These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1150 related articles for article (PubMed ID: 32815653)
21. Systematic analysis of immune-related genes based on a combination of multiple databases to build a diagnostic and a prognostic risk model for hepatocellular carcinoma. Wen DG; Zhao XP; You Y; Liu ZJ Cancer Immunol Immunother; 2021 Mar; 70(3):773-786. PubMed ID: 32989553 [TBL] [Abstract][Full Text] [Related]
22. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma. Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766 [TBL] [Abstract][Full Text] [Related]
23. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma. Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201 [TBL] [Abstract][Full Text] [Related]
24. System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma. Xu JH; Guan YJ; Qiu ZD; Zhang X; Zi LL; Zhou Y; Chen C; Yu J; Zhang YC; Wang WX Oxid Med Cell Longev; 2021; 2021():6485871. PubMed ID: 34795841 [TBL] [Abstract][Full Text] [Related]
25. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies. Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J Front Immunol; 2024; 15():1244392. PubMed ID: 38694506 [TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
27. Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma. Qian H; Song S; Tian Y; Qi L; Gao H; Yuan L Medicine (Baltimore); 2021 Apr; 100(15):e25374. PubMed ID: 33847635 [TBL] [Abstract][Full Text] [Related]
28. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
29. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
30. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
31. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma. Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352 [TBL] [Abstract][Full Text] [Related]
32. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma. Lai J; Yang H; Xu T BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080 [TBL] [Abstract][Full Text] [Related]
33. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment. Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416 [TBL] [Abstract][Full Text] [Related]
34. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
35. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma. Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration. Liu Z; Zhang D; Liu C; Li G; Chen H; Ling H; Zhang F; Huang D; Wang X; Liu Y; Zhang X Front Immunol; 2021; 12():659184. PubMed ID: 33995379 [TBL] [Abstract][Full Text] [Related]
37. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL Front Immunol; 2021; 12():781087. PubMed ID: 35069553 [TBL] [Abstract][Full Text] [Related]
38. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
39. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866 [TBL] [Abstract][Full Text] [Related]
40. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]